Tracking Cathie Wood: ARK Invest significantly increased its stake in AI-powered autonomous driving company Pony AI by over 160,000 shares, while reducing positions in satellite communications and medical diagnostics stocks

On Tuesday, all three major U.S. equity indices closed higher. The S&P 500 rose 0.89% to close at 7,509.20; the Nasdaq performed even stronger, gaining 1.29% to close at 25,837.21; and the Dow Jones Industrial Average posted a solid gain of 0.74%, closing at 52,224.64, reflecting broad strength across tech stocks.

On Tuesday, Cathie Wood significantly increased her stake in core AI-powered autonomous driving companies while adjusting positions in traditional communications infrastructure and medical diagnostics sectors, demonstrating her continued bet on disruptive innovation and dynamic portfolio optimization.

Buying Focus: Heavy bets on the AI autonomous driving theme, with precision medicine and digital finance advancing in parallel

ARK’s largest trade on Tuesday was an increase in$Pony AI (PONY.US)$ 163,163 shares, reflecting strong confidence in the commercialization prospects of autonomous driving. Pony AI, a global leader in Robotaxi operations, has already deployed its Level 4 autonomous driving technology at scale across multiple cities. As regulatory frameworks gradually open up worldwide, the autonomous driving industry is approaching a commercial inflection point.

It also bought$WeRide (WRD.US)$ 24,951 shares, further intensifying its exposure to the autonomous driving sector. The two companies create synergies by covering different technological approaches and geographic markets, aligning with ARK’s investment philosophy of diversifying risk while concentrating bets on core thematic areas.

In precision medicine, ARK increased its stake in$Prime Medicine (PRME.US)$ 76,393 shares. The company specializes in gene-editing technology, and its Prime Editing platform shows significant potential in treating genetic diseases. With continuous improvements in the regulatory environment for gene therapies, precision medicine is poised to become the next decade’s disruptive growth driver.

Emerging technology positions also warrant attention: increased holdings$Securitize (SECZ.US)$ 16,665 shares, betting on digital asset infrastructure; bought$Absci Corp (ABSI.US)$ 16,562 shares, positioning in AI-driven drug discovery platforms; increased holdings$Kodiak AI (KDK.US)$ 12,400 shares, strengthening exposure to autonomous trucking; and added$X-Energy (XE.US)$ 4,277 shares, bullish on the outlook for advanced nuclear energy technologies.

On the sell side: adjusting allocations in traditional healthcare and communications infrastructure to optimize portfolio structure

The largest selling action was a reduction of$Strata Critical Medical (SRTA.US)$ 128,829 shares, possibly reflecting ARK's relatively cautious stance on the traditional medical devices sector. Compared to AI-driven precision medicine, traditional medical equipment faces fiercer competition and slower technological iteration.

It also reduced its position in$Iridium Communications (IRDM.US)$ 114,861 shares, adjusting positions in this satellite communications service provider. Although low-earth orbit satellite communications holds long-term growth potential, it may face intense near-term competition from new entrants like SpaceX; ARK’s decision to moderately reduce position concentration represents a prudent risk management strategy.

Additionally, it trimmed positions in$CareDx (CDNA.US)$ 91,904 shares, as this company specializing in organ transplant monitoring may have seen a shift in priority within ARK’s precision medicine portfolio. Reduced holdings$Brera Holdings (SLMT.US)$ 4,609 shares may reflect a minor position optimization.

Overall, Cathie Wood’s trading activity on Tuesday continued her consistent investment theme of 'disruptive innovation,' further increasing exposure to core areas such as AI-driven autonomous driving and precision medicine, while moderately reducing holdings in more mature traditional tech sectors—demonstrating a balanced investment approach and precise judgment on future technology trends.

Futubull’s [Opportunities Page] now features celebrity portfolio tracking! Choose from multiple celebrity holdings, follow top investors’ moves with one click, precisely target quality stocks, and invest with greater confidence!

90K Views